Location: San Diego, CA
CIK: 0002018299 · Show all filings
Period: Q3 2025 (← Previous) (Next →)
Filing Date: Feb 17, 2026
Total Value: $314M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| TNGX | TANGO THERAPEUTICS INC | 9,771,485 | $82.08M | 26.2% | $4.64 | +45.8% | COM | 87583X109 |
| QURE | UNIQURE NV | 800,000 | $46.7M | 14.9% | $9.43 | +92.5% | SHS | N90064101 |
| RVMD | REVOLUTION MEDICINES INC | 400,000 | $18.68M | 6.0% | $50.47 | -22.4% | COM | 76155X100 |
| KYMR | KYMERA THERAPEUTICS INC | 319,100 | $18.06M | 5.8% | $42.51 | +6.1% | COM | 501575104 |
| KOD | KODIAK SCIENCES INC | 750,000 | $12.28M | 3.9% | $5.74 | +50.2% | COM | 50015M109 |
| PTCT | PTC THERAPEUTICS INC | 200,000 | $12.27M | 3.9% | $52.09 | 0.0% | COM | 69366J200 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 900,000 | $12.23M | 3.9% | $4.71 | +100.0% | COM | 03237H101 |
| URGN | UROGEN PHARMA LTD | 575,000 | $11.47M | 3.7% | $9.60 | +87.1% | COM | M96088105 |
| — | MERUS N V | 120,000 | $11.3M | 3.6% | $42.05 | — | COM | N5749R100 |
| CYTK | CYTOKINETICS INC | 200,000 | $10.99M | 3.5% | $41.20 | 0.0% | COM NEW | 23282W605 |
| ABVX | ABIVAX SA | 120,000 | $10.19M | 3.2% | $84.90 | — | SPONSORED ADS | 00370M103 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 110,000 | $7.307M | 2.3% | $52.01 | +9.3% | COM | 74366E102 |
| NKTR | NEKTAR THERAPEUTICS | 125,000 | $7.112M | 2.3% | $11.24 | +194.6% | COM NEW | 640268306 |
| CBIO | CRESCENT BIOPHARMA INC. | 453,686 | $5.394M | 1.7% | $21.15 | -37.3% | COM | G2545C104 |
| INO | INOVIO PHARMACEUTICALS INC | 2,300,000 | $5.382M | 1.7% | $1.91 | 0.0% | COM SHS | 45773H409 |
| SRPT | SAREPTA THERAPEUTICS INC | 250,000 | $4.817M | 1.5% | $20.31 | -12.2% | COM | 803607100 |
| — | CIDARA THERAPEUTICS INC | 48,000 | $4.596M | 1.5% | $48.71 | — | COM NEW | 171757206 |
| CELC | CELCUITY INC | 90,000 | $4.446M | 1.4% | $40.03 | 0.0% | COM | 15102K100 |
| REPL | REPLIMUNE GROUP INC | 1,050,000 | $4.399M | 1.4% | $11.51 | -44.5% | COM | 76029N106 |
| SLDB | SOLID BIOSCIENCES INC | 600,000 | $3.702M | 1.2% | $5.85 | 0.0% | COM NEW | 83422E204 |
| DNLI | DENALI THERAPEUTICS INC | 250,000 | $3.63M | 1.2% | $14.37 | 0.0% | COM | 24823R105 |
| PGEN | PRECIGEN INC | 850,000 | $2.796M | 0.9% | $2.82 | 0.0% | COM | 74017N105 |
| APGE | APOGEE THERAPEUTICS INC | 50,000 | $1.986M | 0.6% | $38.18 | 0.0% | COM | 03770N101 |
| — | MIND MEDICINE MINDMED INC | 163,500 | $1.928M | 0.6% | $11.79 | — | COM NEW | 60255C885 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 250,000 | $1.792M | 0.6% | $52.12 | 0.0% | CLASS A ORD | 61559X104 |
| NRIX | NURIX THERAPEUTICS INC | 175,000 | $1.617M | 0.5% | $22.92 | -54.7% | COM | 67080M103 |
| AVTX | AVALO THERAPEUTICS INC | 125,000 | $1.589M | 0.5% | $8.60 | 0.0% | COM NEW | 05338F306 |
| MIST | MILESTONE PHARMACEUTICALS IN | 666,666 | $1.333M | 0.4% | $1.76 | 0.0% | COM | 59935V107 |
| PEPG | PEPGEN INC | 250,000 | $1.155M | 0.4% | $1.61 | 0.0% | COM | 713317105 |
| LBRX | LB PHARMACEUTICALS INC | 70,000 | $1.105M | 0.4% | $15.87 | 0.0% | COM SHS | 50180M108 |
| TIL | INSTIL BIO INC | 60,700 | $1.084M | 0.3% | $30.49 | -16.8% | COM NEW | 45783C200 |
| KALV | KALVISTA PHARMACEUTICALS INC | 20,400 | $248K | 0.1% | $12.23 | +13.0% | COM | 483497103 |
| — | NUVATION BIO INC | 266,666 | $53,893 | 0.0% | $0.23 | — | *W EXP 02/10/202 | 67080N119 |
| SRZNW | SURROZEN INC | 66,666 | $1,000 | 0.0% | $0.02 | — | *W EXP 08/01/203 | 86889P117 |